 The purpose of this pilot study is to compare the virological efficacy, as measured by the proportion of patients with plasma HIV-RNA below the limit of detection 50 copiesmL, of two ARV regimens; patients are randomized to remain on regimens containing NtRTIs PIr or switch to Raltegravir ATV but without NtRTIs. 